Your browser doesn't support javascript.
loading
Radiosensitizing effect of galunisertib, a TGF-ß receptor I inhibitor, on head and neck squamous cell carcinoma in vitro.
Jank, Bernhard J; Lenz, Teresa; Haas, Markus; Kadletz-Wanke, Lorenz; Campion, Nicholas J; Schnoell, Julia; Heiduschka, Gregor; Macfelda, Karin.
Affiliation
  • Jank BJ; Department of Otorhinolaryngology, Head and Neck Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. bernhard.jank@meduniwien.ac.at.
  • Lenz T; Department of Biomedical Research, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. bernhard.jank@meduniwien.ac.at.
  • Haas M; Department of Otorhinolaryngology, Head and Neck Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
  • Kadletz-Wanke L; Department of Otorhinolaryngology, Head and Neck Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
  • Campion NJ; Department of Otorhinolaryngology, Head and Neck Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
  • Schnoell J; Department of Otorhinolaryngology, Head and Neck Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
  • Heiduschka G; Department of Otorhinolaryngology, Head and Neck Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
  • Macfelda K; Department of Otorhinolaryngology, Head and Neck Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Invest New Drugs ; 40(3): 478-486, 2022 06.
Article in En | MEDLINE | ID: mdl-34985593

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiation-Sensitizing Agents / Head and Neck Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Invest New Drugs Year: 2022 Document type: Article Affiliation country: Austria Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiation-Sensitizing Agents / Head and Neck Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Invest New Drugs Year: 2022 Document type: Article Affiliation country: Austria Country of publication: United States